NASDAQ:PAVM
PAVmed Inc Stock News
$2.25
+0.0500 (+2.27%)
At Close: May 09, 2024
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
06:33am, Monday, 22'nd Aug 2022 Benzinga
Gainers
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.
Aeglea BioTherapeutics, Inc. (NASDAQ:
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
08:59am, Thursday, 18'th Aug 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced it plans to explore the potential development of a novel monkeypox vac
Nasdaq Down 75 Points After Fed Minutes; Crude Oil Rises 1.5%
06:44pm, Wednesday, 17'th Aug 2022 Benzinga
U.S. stocks pared some losses toward the end of trading, following the release of Federal Reserve minutes.
The Dow traded down 0.11% to 34,113.71 while the NASDAQ fell 0.58% to 13,022. The S&P also f
Dow Falls 250 Points; Lowe's Posts Upbeat Earnings
04:24pm, Wednesday, 17'th Aug 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping 250 points on Wednesday.
The Dow traded down 0.75% to 33,897.14 while the NASDAQ fell 1.59% to 12,894.13. The S&P also fell
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
04:03pm, Wednesday, 17'th Aug 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus
PAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2022 Results - Earnings Call Transcript
08:42pm, Tuesday, 16'th Aug 2022
PAVmed Inc. (NASDAQ:PAVM ) Q2 2022 Earnings Conference Call August 16, 2022 4:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Co
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
10:07am, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2
PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress
02:45pm, Tuesday, 05'th Jul 2022
PAVmed established an interesting hub and spoke business model with joint services and selling stakes in commercially ready technologies. This opens up new financing streams and potentially a lot of v
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
09:35am, Friday, 24'th Jun 2022 Benzinga
Gainers
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown offer
PAVmed Inc.'s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript
09:19pm, Thursday, 12'th May 2022
PAVmed Inc. (NASDAQ:PAVM ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Confe
3 Short Squeeze Penny Stocks To Buy For Under $5 This Week
04:39pm, Monday, 09'th May 2022 PennyStocks
Short squeeze penny stocks to watch this week.
The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Short Squeeze Penny Stocks To Buy For Under $5 This Week
12:39pm, Monday, 09'th May 2022
Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit
08:05pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced a proce
PAVmed Inc. (PAVM) CEO Lishan Aklog on Q4 2021 Results - Earnings Call Transcript
11:44pm, Tuesday, 29'th Mar 2022
PAVmed Inc. (PAVM) CEO Lishan Aklog on Q4 2021 Results - Earnings Call Transcript
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
11:41am, Tuesday, 29'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Announces Positive Results From Second Late-Stage Study Of Ulcerative Colitis Drug
Pfizer, Inc.